Loading…
Loading grant details…
| Funder | European Commission |
|---|---|
| Recipient Organization | Assistance Publique Hopitaux de Paris |
| Country | France |
| Start Date | Nov 01, 2023 |
| End Date | Oct 31, 2028 |
| Duration | 1,826 days |
| Number of Grantees | 18 |
| Roles | Participant; Coordinator; Third Party; Associated Partner |
| Data Source | European Commission |
| Grant ID | 101080964 |
Liver transplantation (LT) is a life-saving procedure for decompensated cirrhosis (DC) and hepato-cellular carcinoma (HCC). Its efficacy is hampered by the risk of death/drop-out on the Wait List (WL). This risk is driven by organ shortage and is mitigated by organ offering schemes.
According to a sickest first policy, offering schemes prioritize LT candidates with the highest risk of dying, as assessed by predictive models.
To drive allocation, Organ Sharing Organizations (OSOs) use a 20-year-old model, the MELD, predicting mortality in DC but not in HCC.
Because of a dramatic increase in % of HCC candidates (40% against 10% in early 20ties), MELD schemes are increasingly inaccurate, with persisting 15 to 30% mortality in countries with low/medium donation rate.
This scenario, together with advances in prognosis in DC and HCC candidates and statistics, prompts LT community to look for up-dated algorithms to refine offering schemes.
To address this issue, key European LT stakeholders including OSOs, experts in LT, Statisticians, Research Labs and SME joined LEOPARD.
Building on an innovative, harmonized OSOs pre-LT dataset and advances in modeling, LEOPARD propose to design and validate 1) an AI-based LEOPARD predictive algorithm outperforming current allocation models by better stratifying patients on the risk of mortality, to be proposed OSOs to drive allocation; 2) DC & HCC LEOPARD calculators available for professional for assistance in complex decision-making processes; 3) OMICs/radiomics predictive signatures integrated in a prototype 3rd-generation exploratory model.
We expect to generate computational tools improving candidates outcomes, with more patients transplanted on time.
Adoption of these tools should result in harmonization of European heterogeneous prioritization schemes, and in a signification reduction in disparities of access to LT, a major objective pointed out by EC. LEOPARD should place Europe in leading position for organ offering schemes.
Ecrin European Clinical Research Infrastructure Network; Institut National de la Sante Et de la Recherche Medicale; Assistance Publique Hopitaux de Paris; Istituto Superiore Di Sanita; Agence de la Biomedecine; Fundacion Para la Investigacion Del Hospital Universitario la Fe de la Comunidad Valenciana; Finovatis; Stichting Eurotransplant International Foundation; Universite Du Luxembourg; Universitatsklinikum Heidelberg; Universite Paris Cite; European Association for the Studyof the Liver; Ophiomics - Investigacao E Desenvolvimento Em Biotecnologia Sa; European Society for Organ Transplantation; European Liver Patients Association; Organizacion Nacional de Trasplantes; European Foundation for the Study of Chronic Liver Failure (Ef-Clif); Fédération Nationale Des Malades Et Transplantés Hépatiques
Complete our application form to express your interest and we'll guide you through the process.
Apply for This Grant